Oct 10, 2016
Nadeem Sarwar PhD, President, Eisai AiM Institute talks about the dramatic changes taking place in the development of targeted theraputics because of the introduction of human genomic data rather than just relying on animal testing, building more sophisticated drug discovery models, and how the timing of intervention is shifting to earlier in the disease cycle.
@EisaiUS